SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-20-000029
Filing Date
2020-08-06
Accepted
2020-08-06 16:54:15
Documents
88
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-20200630.htm   iXBRL 10-Q 2234676
2 EX-31.1 pcrx-6302020xex311.htm EX-31.1 14445
3 EX-31.2 pcrx-6302020xex312.htm EX-31.2 14453
4 EX-32.1 pcrx-6302020xex321.htm EX-32.1 10530
10 pcrx-20200630_g1.jpg GRAPHIC 27796
  Complete submission text file 0001396814-20-000029.txt   9637648

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20200630.xsd EX-101.SCH 54560
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20200630_cal.xml EX-101.CAL 95181
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20200630_def.xml EX-101.DEF 344492
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20200630_lab.xml EX-101.LAB 707246
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20200630_pre.xml EX-101.PRE 493331
11 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20200630_htm.xml XML 1786158
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 201082475
SIC: 2834 Pharmaceutical Preparations